Frederic Jackson
Impact in
- Infectious Diseases top 0.2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Modeling and Simulation top 1%
- COVID-19 epidemiological studies
Papers in
-
- SARS-CoV-2 and COVID-19 Research 5
-
- Neonatal Respiratory Health Research 1
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 1
- Co-authors
- Jesper J. Madsen (1 shared paper)Gregory A. Voth (1 shared paper)Agnieszka Martyna (1 shared paper)Jeremy S. Rossman (1 shared paper)Altar M. Munis (1 shared paper)Benjamin Wright (1 shared paper)Helen E. Lockstone (1 shared paper)Stephen C. Hyde (1 shared paper)
- Journals
- The Lancet (3 papers)Nature Medicine (2 papers)Molecular Therapy — Methods & Clinical Development (1 paper)The Journal of Physical Chemistry B (1 paper)
- Partner nations
- United KingdomUnited States
In The Last Decade
Frederic Jackson
7 papers receiving 7k citations
Frederic Jackson's Hit Papers
Peers
Comparison fields: 5 of 124
- Infectious Diseases 5.4k
- Modeling and Simulation 329
- Health 431
- Toxicology 105
- General Dentistry 7
Countries citing papers authored by Frederic Jackson
This map shows the geographic impact of Frederic Jackson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederic Jackson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederic Jackson more than expected).
Fields of papers citing papers by Frederic Jackson
This network shows the impact of papers produced by Frederic Jackson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederic Jackson. The network helps show where Frederic Jackson may publish in the future.
Co-authors
The 10 scholars most cited alongside Frederic Jackson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK Hit paper breakdown → | 2020 | 3698 |
| 2 | Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial Hit paper breakdown → | 2020 | 1939 |
| 3 | Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials Hit paper breakdown → | 2021 | 894 |
| 4 | 2020 | 481 | |
| 5 | 2020 | 257 | |
| 6 | 2020 | 21 | |
| 7 | 2021 | 5 |
About Frederic Jackson
Frederic Jackson is a scholar working on Infectious Diseases, Pulmonary and Respiratory Medicine, Molecular Biology, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 7 papers that have together received 7.3k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (5 papers), Lipid Membrane Structure and Behavior (1 paper), Neonatal Respiratory Health Research (1 paper) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (1 paper). The work is most often cited by research in Infectious Diseases (5.4k citations), Modeling and Simulation (329 citations), Health (431 citations), Toxicology (105 citations) and General Dentistry (7 citations). Frederic Jackson has collaborated with scholars based in United Kingdom and United States. Frequent co-authors include Jesper J. Madsen, Gregory A. Voth, Agnieszka Martyna, Jeremy S. Rossman, Altar M. Munis, Benjamin Wright, Helen E. Lockstone, Stephen C. Hyde, Deborah R. Gill and Catherine Green. Their work appears in journals such as The Lancet, Nature Medicine, Molecular Therapy — Methods & Clinical Development and The Journal of Physical Chemistry B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.